Associated daily biosynthesis of cortisol and thromboxane A2: A preliminary report

Journal of Laboratory and Clinical Medicine - Tập 128 - Trang 115-121 - 1996
Filippo Luca Fimognari1,2, Gianfranco Piccirillo1,2, Jaime Lama1,2, Patrizia Paganica1,2, Girolamo Monteleone1,2, Walter Gianni1,2, Mauro Cacciafesta1,2, Vincenzo Marigliano1,2
1First Medical Clinic, University “La Sapienza”, Rome, Italy
2Laboratory of Clinical Pathology, Leopoldo Maria Vanni del Balzo Squillacioti e Francesco Teotino Hospital, Locri, Italy

Tài liệu tham khảo

Dalack, 1990, Perspectives on the relationship between cardiovascular disease and affective disorder, J Clin Psychiatry, 51, 4 Frasure-Smith, 1993, Depression following myocardial infarction: impact on 6-month survival, JAMA, 270, 1819, 10.1001/jama.1993.03510150053029 Axelrod, 1984, Stress hormones: their interaction and regulation, Science, 225, 452, 10.1126/science.6143403 Sachar, 1970, Cortisol production in depressive illness: a clinical and biochemical clarification, Arch Gen Psychiatry, 23, 289, 10.1001/archpsyc.1970.01750040001001 Piccirillo, 1994, High plasma concentrations of cortisol and thromboxane B2 in patients with depression, Am J Med Sci, 307, 228, 10.1097/00000441-199403000-00011 Hamberg, 1975, Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, 72, 2994 Fitzgerald, 1986, Platelet activation in unstable coronary disease, N Engl J Med, 35, 983, 10.1056/NEJM198610163151602 Koudstaal, 1993, Increased thromboxane biosynthesis in patients with acute cerebral ischemia, Stroke, 24, 219, 10.1161/01.STR.24.2.219 Rebuzzi, 1992, Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis, Am Heart J, 123, 560, 10.1016/0002-8703(92)90491-D The American Psychiatric Association, 1987 1972, 45, 501 Spielberger, 1970 Patrono, 1985, Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus, J Clin Invest, 76, 1011, 10.1172/JCI112053 Brock, 1978, Direct solid-phase 125I radioimmunoassay of serum cortisol, Clin Chem, 24, 1595, 10.1093/clinchem/24.9.1595 Patrono, 1985, Estimated rate of thromboxane secretion into the circulation of normal humans, J Clin Invest, 77, 590, 10.1172/JCI112341 Vejar, 1990, Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina, Thromb Haemost, 63, 163, 10.1055/s-0038-1645038 Montalescot, 1991, Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris, Circulation, 84, 2054, 10.1161/01.CIR.84.5.2054 Davi, 1992, Increased thromboxane biosynthesis in type IIA hypercholesterolemia, Circulation, 85, 1792, 10.1161/01.CIR.85.5.1792 Emoto, 1983, Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain, Pharmacol Biochem Behav, 45, 419, 10.1016/0091-3057(93)90259-V Melia, 1991, Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system, 88, 8382 Tsagarakis, 1988, Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro, Endocrinology, 123, 1962, 10.1210/endo-123-4-1962 Ardlie, 1985, Effect on human platelets of catecholamines at levels achieved in the circulation, Atherosclerosis, 58, 251, 10.1016/0021-9150(85)90070-X O'Brien, 1963, Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo, Nature, 200, 763, 10.1038/200763a0 Hjemdahl, 1991, Effects of stress and beta-blockade on platelet function, Circulation, 84, V144 Larsson, 1994, Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin, Circulation, 89, 1951, 10.1161/01.CIR.89.5.1951 Grignani, 1991, Platelet activation by emotional stress in patients with coronary artery disease, Circulation, 83, 128 Haft, 1976, Effect of emotional stress on platelet aggregation in humans, Chest, 70, 501, 10.1378/chest.70.4.501 Tohgi, 1992, Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin, Stroke, 23, 1400, 10.1161/01.STR.23.10.1400 Moncada, 1979, Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin, Pharmacol Rev, 30, 293 Tsagakaris, 1989, Interleukin-1 directly stimulates the release of corticotropinreleasing factor from rat hypothalamus, Neuroendocrinology, 49, 98, 10.1159/000125096 Revhaug, 1988, Inhibition of cyclooxygenase attenuates the metabolic response to endotoxin in humans, Arch Surg, 123, 162, 10.1001/archsurg.1988.01400260042004 Tewari, 1990, Preliminary report: effects of interleukin-1 on platelet counts, Lancet, 336, 712, 10.1016/0140-6736(90)92206-W Weitzman, 1971, Twenty-four hour pattern of episodic secretion of cortisol in normal subjects, J Clin Endocrinol Metab, 33, 14, 10.1210/jcem-33-1-14 Tofler, 1987, Concurrent morning increase in platelet aggregability and risk of myocardial infarction and sudden cardiac death, N Engl J Med, 316, 1514, 10.1056/NEJM198706113162405 Muller, 1989, Circadian variation and triggers of onset of acute cardiovascular disease, Circulation, 79, 733, 10.1161/01.CIR.79.4.733